ConductScience.org, home

Paper32551978

Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits.

Jain N and 2 others. Drug Deliv, 2020. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits. Papers, record 32551978. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32551978

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits.
PubMed
Journal
Drug Deliv
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
2.71
iCite
Revised in PubMed
2024-04-02
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jain NNeelam
2Verma AAnurag
3Jain NNeeraj

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug Delivery SystemsMajor topic
Intraocular PressureMajor topic
LiposomesMajor topic
PilocarpineMajor topic
Administration, Ophthalmic
Animals
Chemistry, Pharmaceutical
Drug Liberation
Drug Stability
Glaucoma
Hexoses
Particle Size
Rabbits

Source PubMed

Download CSV of topics

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112062505Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating.Int J Pharm2002https://conductscience.org/library/papers/12062505PubMed
225356469
1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987.
J Control Release2014https://conductscience.org/library/papers/25356469PubMed
310697760Nonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemias: encapsulation, storage, and in vitro release.Drug Dev Ind Pharm2000https://conductscience.org/library/papers/10697760PubMed
415120486The inflow and outflow of anti-glaucoma drugs.Trends Pharmacol Sci2004https://conductscience.org/library/papers/15120486PubMed
511719010Lidocaine-loaded non-ionic surfactant vesicles: characterization and in vitro permeation studies.Int J Pharm2002https://conductscience.org/library/papers/11719010PubMed
619780133Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery.J Pharm Sci2010https://conductscience.org/library/papers/19780133PubMed
727293976In Vitro and In Vivo Evaluation of Niosomal Formulation for Controlled Delivery of Clarithromycin.Scientifica (Cairo)2016https://conductscience.org/library/papers/27293976PubMed
823131800In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide.Eur J Pharm Sci2013https://conductscience.org/library/papers/23131800PubMed
916290741Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol.J Colloid Interface Sci2002https://conductscience.org/library/papers/16290741PubMed
1015021223Current management of glaucoma.Curr Opin Ophthalmol2004https://conductscience.org/library/papers/15021223PubMed
1124672401Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement.ScientificWorldJournal2014https://conductscience.org/library/papers/24672401PubMed
1216198021The use of mucoadhesive polymers in ocular drug delivery.Adv Drug Deliv Rev2005https://conductscience.org/library/papers/16198021PubMed
1311297896Modeling and comparison of dissolution profiles.Eur J Pharm Sci2001https://conductscience.org/library/papers/11297896PubMed
1423104306Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel.AAPS PharmSciTech2012https://conductscience.org/library/papers/23104306PubMed
1527091293Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery.Int J Pharm2016https://conductscience.org/library/papers/27091293PubMed
1612852427Introduction: three targets for glaucoma management.Surv Ophthalmol2003https://conductscience.org/library/papers/12852427PubMed
1710425362Proniosomes: a novel drug carrier preparation.Int J Pharm1999https://conductscience.org/library/papers/10425362PubMed
189742041Discoidal niosome based controlled ocular delivery of timolol maleate.Pharmazie1998https://conductscience.org/library/papers/9742041PubMed
1915158634Primary open-angle glaucoma.Lancet2004https://conductscience.org/library/papers/15158634PubMed
20311169Experimental corticosteroid ocular hypertension in the rabbit.Albrecht Von Graefes Arch Klin Exp Ophthalmol1978https://conductscience.org/library/papers/311169PubMed

See all 27 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
42769214Mannitol plus pilocarpine for primary acute angle-closure glaucoma: efficacy and safety analysis.Am J Transl Res2026https://conductscience.org/library/papers/42769214PubMed
40702295Nanovesicular Drug Delivery Systems for Rare Ocular Diseases: Advances, Challenges, and Future Directions.AAPS PharmSciTech2025https://conductscience.org/library/papers/40702295PubMed
40284442Topical Ocular Drug Delivery: The Impact of Permeation Enhancers.Pharmaceutics2025https://conductscience.org/library/papers/40284442PubMed
39697473Bioadhesive hybrid system of niosomes and pH sensitive in situ gel for itraconazole ocular delivery: Dual approach for efficient treatment of fungal infections.Saudi Pharm J2024https://conductscience.org/library/papers/39697473PubMed
38380035Langmuir monolayer studies of non-ionic surfactants and DOTMA for the design of ophthalmic niosomes.Heliyon2024https://conductscience.org/library/papers/38380035PubMed
38254071Anti-rheumatic colchicine phytochemical exhibits potent antiviral activities against avian and seasonal Influenza A viruses (IAVs) via targeting different stages of IAV replication cycle.BMC Complement Med Ther2024https://conductscience.org/library/papers/38254071PubMed
38158475Development of brimonidine niosomes laden contact lenses for extended release and promising delivery system in glaucoma treatment.Daru2024https://conductscience.org/library/papers/38158475PubMed
37587812Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.Pharm Nanotechnol2024https://conductscience.org/library/papers/37587812PubMed
37299085Potential Distribution of Pilocarpus microphyllus in the Amazonia/Cerrado Biomes under Near-Future Climate Change Scenarios.Plants (Basel)2023https://conductscience.org/library/papers/37299085PubMed
36987154Breaking Barriers in Eye Treatment: Polymeric Nano-Based Drug-Delivery System for Anterior Segment Diseases and Glaucoma.Polymers (Basel)2023https://conductscience.org/library/papers/36987154PubMed
36826309Preparation and Characterization of Silymarin Gel: A Novel Topical Mucoadhesive Formulation for Potential Applicability in Oral Pathologies.Gels2023https://conductscience.org/library/papers/36826309PubMed
35494641Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds.Front Chem2022https://conductscience.org/library/papers/35494641PubMed
35277107Sorafenib-loaded nanostructured lipid carriers for topical ocular therapy of corneal neovascularization: development, in-vitro and in vivo study.Drug Deliv2022https://conductscience.org/library/papers/35277107PubMed
35235173In Vitro and In-Eye Comparison of Commercial Pilocarpine Ophthalmic Solution and an Optimized, Reformulated Pilocarpine for Presbyopia Treatment.Ophthalmol Ther2022https://conductscience.org/library/papers/35235173PubMed
35174743Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma.Drug Deliv2022https://conductscience.org/library/papers/35174743PubMed
34218424The Emerging Role of Topical Ocular Drugs to Target the Posterior Eye.Ophthalmol Ther2021https://conductscience.org/library/papers/34218424PubMed
34208623Concise Synthesis of Both Enantiomers of Pilocarpine.Molecules2021https://conductscience.org/library/papers/34208623PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32551978

GET https://conductscience.org/api/papers/v1/32551978/references?page=2